[4-[2-(2-amino-3-pyridinyl)-5-(1-propan-2-yltriazol-4-yl)imidazo[4,5-b]pyridin-3-yl]phenyl]methanol
C23H22N8O — CID 171599297
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-[2-(2-amino-3-pyridinyl)-5-(1-propan-2-yltriazol-4-yl)imidazo[4,5-b]pyridin-3-yl]phenyl]methanol
[4-[2-(2-amino-3-pyridinyl)-5-(1-propan-2-yltriazol-4-yl)imidazo[4,5-b]pyridin-3-yl]phenyl]methanol (PubChem CID 171599297) has the molecular formula C23H22N8O and a molecular weight of 426.48 g/mol. Its IUPAC name is [4-[2-(2-amino-3-pyridinyl)-5-(1-propan-2-yltriazol-4-yl)imidazo[4,5-b]pyridin-3-yl]phenyl]methanol.
Molecular Properties
| Compound Name | [4-[2-(2-amino-3-pyridinyl)-5-(1-propan-2-yltriazol-4-yl)imidazo[4,5-b]pyridin-3-yl]phenyl]methanol |
|---|---|
| PubChem CID | 171599297 |
| Molecular Formula | C23H22N8O |
| Molecular Weight | 426.48 g/mol |
| Exact Mass | 426.19 |
| IUPAC Name | [4-[2-(2-amino-3-pyridinyl)-5-(1-propan-2-yltriazol-4-yl)imidazo[4,5-b]pyridin-3-yl]phenyl]methanol |
| SMILES | CC(C)n1cc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CO)cc4)c3n2)nn1 |
| InChI | InChI=1S/C23H22N8O/c1-14(2)30-12-20(28-29-30)18-9-10-19-23(26-18)31(16-7-5-15(13-32)6-8-16)22(27-19)17-4-3-11-25-21(17)24/h3-12,14,32H,13H2,1-2H3,(H2,24,25) |
| InChIKey | YBVMPRLUUOYQIE-UHFFFAOYSA-N |
| XLogP | 3.40 |
| TPSA | 120.56 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 426.48 |
| LogP ≤ 5 | 3.40 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171599297 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.